Homecare Oxygen Market Growth, Size, Demand, Forecast With Depth Assessment By Top Key Players 2027

By Author: Brand Essence
Total Articles: 1
Comment this article

Homecare Oxygen Concentrators Market is valued at USD 0.85 billion in 2017 and expected to reach USD 1.91 billion by 2027 | CAGR of 8.40%

"Rising prevalence of pulmonary hypertension, COPD, fibrosis, chronic respiratory and pulmonary disorders, will drive homecare oxygen concentrators market over forecast period.

The Homecare Oxygen Concentrators Market is valued at USD 0.85 billion in 2017 and expected to reach USD 1.91 billion by 2027 with a CAGR of 8.4% over the forecast period

Get Sample of the Report; https://brandessenceresearch.com/requestSample/PostId/1055

Homecare Oxygen Concentrators Companies:

Some major key players for Global homecare oxygen concentrators market are Inogen, Invacare, Philips Respironics, Chart (Airsep), Inova Labs, Teijin, GCE Group, Drive Medical, Precision Medical, AVIC Jianghang,Foshan Kaiya, Beijing North Starand others.

The homecare oxygen concentrator is a device with the intention to concentrates the oxygen as of a gas supply and air surrounding to large prediction in particular evacuating nitrogen to provide the oxygen-enhanced item gas stream. ...
... The homecare oxygen concentrator take in air as well as expel nitrogen oxygen enhanced gas for use by those requiring healing oxygen because of low oxygen levels in their blood. the oxygen concentrators are utilized by patients requiring supplemental oxygen for aspiratory issue. For example, bronchitis, emphysema, lung malignancy, and intense pneumonia. The oxygen concentrator works by drawing in the air. Therefore, it separates the oxygen from the other gases using a filter system that allows only the oxygen to pass through the patient. Additionally, the people in the room will still be breathing normal amounts of oxygen. The homecare oxygen concentrator the high prevalence of asthma and several & respiratory disorders the growing concentration of carbon dioxide, pollution, and harmful gases in the result from the atmospheres. Hence, the chronic obstructive pulmonary disease (COPD) is generally diagnosed in middle-aged and older people. In severe cases, doctors recommend oxygen therapies with home oxygen concentrators that help with shortness of breath. The home care medical oxygen concentrators include portable and stationary oxygen concentrators, mostly used in home oxygen therapies. The facilitate preserve patients' quality of life and reduce healthcare costs related to this chronic disease, clinicians need to accurately diagnose the condition and appropriately manage patients through the long course of their illness. Examples of these devices are AirSep’s lifestyle Portable oxygen concentrator, inogen one G3, VBOX Trooper, EverGo, Invacare XPO2 and iGo.

Global Homecare Oxygen Concentrators Market Segmentation –

By Product Type: Portable oxygen concentrators, Stationary oxygen concentrators

By Application: Direct Marketing, Distribution Marketing, Rental Marketing

Regional & Country Analysis

North America, U.S., Mexico, Canada , Europe, UK, France, Germany, Italy , Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of Middle East and Africa

Global Homecare Oxygen Concentrators Market Drug Market Regional Analysis –

North America is dominating the homecare oxygen concentrators market due to the highest market share in terms of profits in overall market of homecare oxygen concentrators market across the globe. Increasing spending of people, various government initiatives to spread awareness about disease and increasing geriatric population will stimulate industry growth. According to the World Health Organization (WHO) to U.S. in 2017, the Behavioral Risk Factor Surveillance System survey found that approximately 22.5 million 9.1% of adults residing in the United States and 7.9 percent of children from about 16.3 million adults (6.6 percent) reported being diagnosed with COPD. About 33.2 million adults reported being diagnosed with chronic lung disease. In addition to this rise in population, the prevalence of chronic lung disease associated with them is responsible for the growth of Homecare Oxygen Concentrators market. The Asia Pacific is expected to witness the fastest growth in this market owing to the expanding pervasiveness of COPDs and other respiratory diseases. Moreover, expanding medicinal services use, mindfulness with respect to the mechanical headways utilized in determination, and interest for versatile concentrators are projected to drive the market growth.

Read More: https://brandessenceresearch.com/PressReleases/homecare-oxygen-concentrators-market-is-valued-at-usd-0-85-billion-in